慢性心力衰竭应用缬沙坦联合卡维地洛治疗的临床探讨.docxVIP

慢性心力衰竭应用缠沙坦联合卡维地洛治疗的临床探讨 帅艳红 （乐山市五通桥区人民医院 四川 五通614800） 【摘要】目的：探究在慢性心力衰竭的治疗中采用纟颉沙坦联合卡维地洛治 疗的临床应用效果。方法：选取2012年6月至2014年8月在我院治疗的慢性心 力衰竭患者94例，将其随机分为对照组和治疗组，对照组采取常规的对症治疗 和饮食护理和卡维地洛口服治疗，主要包括低盐饮食以及强心、利尿对症、卡维 地洛服用治疗，治疗组患者则在常规对症治疗的基础上采用绳沙坦联合卡维地洛 治疗，比较两组患者的临床治疗效果。结果：治疗组患者的临床治疗有效率为 95.7%,对照组患者的临床治疗有效率为72.3%,治疗组明显优于对照组，其差 异符合统计学判断标准（PV0.05）。结论：在慢性心力衰渴的临床治疗中联合绷 沙坦和卡维地洛进行治疗能够有效改善患者的临床治疗效果，值得在心内科慢性 心衰的治疗中推广应用。 【关键词】慢性心力衰竭；绷沙坦；卡维地洛 【中图分类号】R453 【文献标识码】A 【文章编号】2095-1752 （2015） 19-0032-02 Chronic heart failure in application of valsartan combined carvedilol treatment of clinical study Shuai Yanhong Leshan wutongqiao district peoples hospital 45, 614800 in sichuan provinee [Abstract] objective To explore in the treatment of chronic heart failure treated with valsartan combined carvedilol clinical application effect. Methods In June 2012 to August 2014 in our hospital treatment of 94 cases of patients with chronic heart failure, were randomly divided into control group and treatment group, control group adopts conventional symptomatic treatment and diet nursing and carvedilol oral treatment, mainly including low salt diet, and strong heart, diuresis, carvedilol take therapy, the treatment group patients is on the basis of conventional symptomatic treatment with valsartan combined carvedilol treatment, compared two groups of patients with the clinical therapeutic effect. Results The treatment group patients clinical effective rate was 95.7%, control group patients clinical effective rate was 72.3%, the treatment group was better than control group, the difference between statistical judgement standard (P lt; 0.05). Conclusions In clinical treatment of chronic heart failure combined valsartan and carvedilol treatment can effectively improve the patients clinical curative effect, worth in cardiology, popularization and application in the treatment of chronic heart failure. 【key words] Chronic heart failure; Valsartan; Carvedilol 随着人口老龄化的不断加剧，生活水平的提高使得心血管疾病的发病率不断 上升。心力衰竭是心血管疾病和心脏病的终末临床病症，患者